Internal Medicine, Hematology & Oncology · East Patchogue, NY
NPI
1851497341
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
285 Sills Rd Bldg 16
East Patchogue, NY, 11772
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
171,639 services
Medicare patients, 2024
1,998
Average age 75
Drug cost, 2024
$5.5M
1,296 prescriptions
Company payments, 2025
$440K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanjeev Jain was code J1439 (injection, ferric carboxymaltose, 1 mg), 63,750 times for 74 patients. In total Sanjeev Jain billed 171,639 services in 244 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 63,750 | 74 | $0.88 | $56K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,800 | 18 | $44.79 | $394K |
| J1756 Injection, iron sucrose, 1 mg | Office | 8,201 | 35 | $0.17 | $1,434 |
| J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | Office | 5,880 | 11 | $0.78 | $4,581 |
| J0897 Injection, denosumab, 1 mg | Office | 3,180 | 31 | $20.54 | $65K |
| 85025 Blood Count | Office | 2,520 | 1,127 | $7.56 | $19K |
| 36415 Venipuncture Blood Collection | Office | 2,504 | 1,141 | $8.64 | $22K |
| 88185 Surgical Pathology Examination | Office | 2,484 | 102 | $21.83 | $54K |
| 80053 Clinical Chemistry | Office | 2,028 | 1,000 | $10.29 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,804 | 101 | $0.09 | $161 |
| 84100 Clinical Chemistry | Office | 1,599 | 882 | $4.61 | $7,378 |
| 83735 Clinical Chemistry | Office | 1,597 | 847 | $6.53 | $10K |
| 83615 Clinical Chemistry | Office | 1,564 | 823 | $5.89 | $9,206 |
| 84550 Clinical Chemistry | Office | 1,499 | 812 | $4.40 | $6,601 |
| 99233 Hospital E&M - Subsequent | Facility | 1,340 | 677 | $104.37 | $140K |
By year: 2022 $3.1M for 230,413 services; 2023 $2.8M for 202,412 services; 2024 $2.1M for 171,639 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,520 | 1,127 | $7.56 | $19K |
| 36415 Venipuncture Blood Collection | 2,504 | 1,141 | $8.64 | $22K |
| 88185 Surgical Pathology Examination | 2,484 | 102 | $21.83 | $54K |
| 80053 Clinical Chemistry | 2,028 | 1,000 | $10.29 | $21K |
| 84100 Clinical Chemistry | 1,599 | 882 | $4.61 | $7,378 |
| 83735 Clinical Chemistry | 1,597 | 847 | $6.53 | $10K |
| 83615 Clinical Chemistry | 1,564 | 823 | $5.89 | $9,206 |
| 84550 Clinical Chemistry | 1,499 | 812 | $4.40 | $6,601 |
| 82728 Clinical Chemistry | 1,304 | 736 | $13.28 | $17K |
| 83540 Clinical Chemistry | 1,281 | 731 | $6.30 | $8,073 |
Medicare prescription drug claims, 2024
In 2024, the drug Sanjeev Jain prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 194 prescriptions and refills. In total Sanjeev Jain wrote 1,296 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 194 | 194 | 49 | $662K |
| Akynzeo Fosnetupitant/Palonosetron | 72 | 72 | 20 | $79K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 71 | 71 | Under 11 | $521K |
| Xarelto Rivaroxaban | 48 | 69 | 14 | $38K |
| Xgeva Denosumab | 38 | 40 | Under 11 | $116K |
| Reblozyl Luspatercept-Aamt | 32 | 32 | Under 11 | $683K |
| Ondansetron Odt Ondansetron | 29 | 29 | 20 | $261 |
| Gabapentin Generic | 29 | 29 | Under 11 | $242 |
| Eliquis Apixaban | 27 | 31 | 13 | $17K |
| Revlimid Lenalidomide | 26 | 26 | Under 11 | $337K |
| Keytruda Pembrolizumab | 25 | 25 | Under 11 | $279K |
| Prednisone Generic | 24 | 24 | Under 11 | $172 |
| Lupron Depot Leuprolide Acetate | 22 | 22 | Under 11 | $45K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 21 | 21 | Under 11 | $476 |
| Mvasi Bevacizumab-Awwb | 20 | 20 | Under 11 | $191K |
Brand drugs: 846 claims; generic drugs: 450 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanjeev Jain $440K ($440K in general payments such as food, travel and fees) from 5 companies. The largest payer was Pfizer Inc. with $362K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.